相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical and Neuroimaging Characterization of Chinese Dementia Patients with PSEN1 and PSEN2 Mutations
Zhihong Shi et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2015)
Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive Impairment
Rong Fang et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2014)
A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family
Jie-Mei Gu et al.
BONE (2013)
Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia
S. G. Mehta et al.
CLINICAL GENETICS (2013)
C9orf72 mutation is rare in Alzheimer's disease, Parkinson's disease, and essential tremor in China
Bin Jiao et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Reliability, Validity, and Optimal Cutoff Score of the Montreal Cognitive Assessment (Changsha Version) in Ischemic Cerebrovascular Disease Patients of Hunan Province, China
Qiu-yun Tu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2013)
The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study
Jing Yu et al.
BMC PSYCHIATRY (2012)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Alzheimer Disease–like Phenotype Associated With the c.154delA Mutation in Progranulin
Brendan J. Kelley et al.
ARCHIVES OF NEUROLOGY (2010)
Frontotemporal Lobar Degeneration Epidemiology, Pathophysiology, Diagnosis and Management
Gil D. Rabinovici et al.
CNS DRUGS (2010)
Progranulin-associated primary progressive aphasia: A distinct phenotype?
Jonathan D. Rohrer et al.
NEUROPSYCHOLOGIA (2010)
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease
Miryam Carecchio et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Prominent phenotypic variability associated with mutations in Progranulin
Brendan J. Kelley et al.
NEUROBIOLOGY OF AGING (2009)
Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation
S. G. Lindquist et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C → T (Arg493X) mutation:: an international initiative
Rosa Rademakers et al.
LANCET NEUROLOGY (2007)
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family
Nathalie Brouwers et al.
ARCHIVES OF NEUROLOGY (2007)
Progranulin mutations in primary progressive aphasia - The PPA1 and PPA3 families
Marsel Mesulam et al.
ARCHIVES OF NEUROLOGY (2007)
Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease
M. Kaleem et al.
NEURODEGENERATIVE DISEASES (2007)
APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD)
Sarju G. Mehta et al.
GENETICS IN MEDICINE (2007)
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia
J. S. Snowden et al.
BRAIN (2006)
Tau protein in familial and sporadic diseases
D Yancopoulou et al.
NEUROMOLECULAR MEDICINE (2003)
Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in western Europe
R Rademakers et al.
HUMAN MUTATION (2003)